Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology-Reference-Cited by-同舟云学术

Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology

Published:2014-04-28 Issue:6 Volume:10 Page:724-734
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Sattlecker Martina¹²,Kiddle Steven J.¹²,Newhouse Stephen¹²,Proitsi Petroula¹²,Nelson Sally³,Williams Stephen³,Johnston Caroline¹²,Killick Richard¹²,Simmons Andrew¹²,Westman Eric¹²,Hodges Angela¹²,Soininen Hilkka⁴,Kłoszewska Iwona⁵,Mecocci Patrizia⁶,Tsolaki Magda⁷,Vellas Bruno⁸,Lovestone Simon¹²,Dobson Richard J.B.¹²,

Affiliation:

1. King's College LondonInstitute of PsychiatryLondonUK

2. NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation TrustLondonUK

3. SomaLogicBoulderCOUSA

4. Department of NeurologyUniversity of Eastern Finland and Kuopio University HospitalKuopioFinland

5. Medical University of LodzLodzPoland

6. Institute of Gerontology and Geriatrics, University of PerugiaPerugiaItaly

7. 3rd Department of NeurologyAristotle UniversityThessalonikiGreece

8. INSERM U 558University of ToulouseToulouseFrance

Funder

NIHR Newcastle Biomedical Research Centre

InnoMed (Innovative Medicines in Europe)

European Union of the Sixth Framework program priority

Alzheimer's Research Trust UK

John and Lucille van Geest Foundation

NIHR Biomedical Research Centre for Mental Health

Maudsley NHS Foundation Trust

Kings College London

Guy's and St Thomas' Charity

Maudsley Charity

Kuopio University Hospital

UEFBRAIN

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2013.09.016

Reference53 articles.

1. Biomarkers for Alzheimer’s disease trials — biomarkers for what? A discussion paper

2. Modeling screening, prevention, and delaying of Alzheimer's disease: an early‐stage decision analytic model;Furiak N.M.;BMC Med Inform Decis Mak,2010

3. Cerebrospinal Fluid Tau and β-Amyloid

4. CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study

5. Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease;Nature Aging;2024-08-21

2. CSF Proteomics in Patients With Progressive Supranuclear Palsy;Neurology;2024-08-13

3. Biomarker Discovery in Alzheimer’s and Neurodegenerative Diseases using Nucleic Acid-Linked Immuno-Sandwich Assay;2024-07-29

4. Nomination of a novel plasma protein biomarker panel capable of classifying Alzheimer’s disease dementia with high accuracy in an African American cohort;2024-07-29

5. Which neuroimaging and fluid biomarkers method is better in theranostic of Alzheimer’s disease? An umbrella review;IBRO Neuroscience Reports;2024-06